Busca avançada
Ano de início
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1

Texto completo
Pontillo, Alessandra [1] ; Da Silva, Ronaldo C. [2] ; Moura, Ronald [2] ; Crovella, Sergio [2]
Número total de Autores: 4
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biol Sci, Dept Immunol, Sao Paulo - Brazil
[2] Univ Fed Pernambuco, Dept Genet, Recife, PE - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: HUMAN VACCINES & IMMUNOTHERAPEUTICS; v. 10, n. 2, p. 512-518, FEB 2014.
Citações Web of Science: 7

Host genome is still poorly investigated in the context of vaccine or immunotherapy, however recently findings emphasized that it may affect the response to those treatments. In our retrospective study we evaluated the effect of HIV-1 genetic restriction factors on the response to dendritic cell (DC)-based immunotherapy in a Brazilian cohort of HIV positive (HIV+) patients that underwent a phase I clinical trial in 2004. Genomic DNA from 18 HIV+ individuals that underwent DC-based immunotherapy was analyzed for selected polymorphisms known to be associated with susceptibility to HIV-1 infection and/or AIDS progression. Allelic and genotypic distribution of the 22 polymorphisms was evaluated considering the response to the treatment. The rs11884476 SNP in PARD3B resulted associated with good response to immune treatment according to an over-dominant model. Even if functional effect of this variation is still unknown, our data suggested that it could play a role in the control of viral replication. Our findings, being aware of the limitation represented by the small number of subjects analyzed, suggest that genetic factors involved in AIDS progression could affect the response to immunotherapy, reinforcing the idea that deeper investigation on host genetic variations will be fundamental for a rational vaccine development. (AU)

Processo FAPESP: 13/06142-1 - Perfil genômico da resposta imune ao HIV-1 e implicações para a vacina terapêutica com células dendríticas contra o HIV-1
Beneficiário:Alessandra Pontillo
Linha de fomento: Auxílio à Pesquisa - Regular